Yilong Zhang
Datos Biográficos
| ID | 4594574 |
|---|---|
| NOMBRE | Yilong Zhang |
| NOMBRES | Yilong |
| APELLIDO | Zhang |
| FIRMA | ZHANG Y |
| AFILIACIONES | Otsuka (Japan) |
| ORCID | 0009-0002-1846-3751 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2019 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2025 |
| ÍNDICE H | 0 |
Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepressants
The MCIDs for the MADRS, SDS, and EQ-5D-5L -derived utility scores were estimated. Physicians focus more on depressive symptoms and prioritize symptom severity over improvements in functionality and activities of daily life, in contrast to patients, who prioritize such improvements
Assessment of the Minimum Clinically Important Difference in Symptoms and Functions of Patients With Acute Schizophrenia
The purpose of this study was to evaluate the application of the minimum clinically important difference (MCID) concept to clinical results in Chinese patients with acutely exacerbated schizophrenia. The original study was an 8-week, open-label, single-arm, multicenter study of flexible doses of paliperidone-extended release (pali-ER) in Chinese patients with acutely exacerbated schizophrenia. This is a post hoc analysis to determine the MCID val…
Dose Adjustment Model of Paliperidone in Patients With Acute Schizophrenia
This study aimed to investigate the factors that influenced the clinicians to adjust the paliperidone dose in the acute phase of schizophrenia. This was a post hoc study of an 8-week, open-label, single-arm multicenter trial which evaluated the efficacy, safety, and tolerability of flexible doses of paliperidone ER (3-12 mg/day) in patients with acutely exacerbated schizophrenia. Patients were divided into groups according to the dose at week 8 (…
Reproducible, interactive, scalable and extensible microbiome data science using Qiime 2
Sin obras prominentes en esta página.
Reproducible, interactive, scalable and extensible microbiome data science using Qiime 2
Assessment of the Minimum Clinically Important Difference in Symptoms and Functions of Patients With Acute Schizophrenia
The purpose of this study was to evaluate the application of the minimum clinically important difference (MCID) concept to clinical results in Chinese patients with acutely exacerbated schizophrenia. The original study was an 8-week, open-label, single-arm, multicenter study of flexible doses of paliperidone-extended release (pali-ER) in Chinese patients with acutely exacerbated schizophrenia. This is a post hoc analysis to determine the MCID val…
Dose Adjustment Model of Paliperidone in Patients With Acute Schizophrenia
This study aimed to investigate the factors that influenced the clinicians to adjust the paliperidone dose in the acute phase of schizophrenia. This was a post hoc study of an 8-week, open-label, single-arm multicenter trial which evaluated the efficacy, safety, and tolerability of flexible doses of paliperidone ER (3-12 mg/day) in patients with acutely exacerbated schizophrenia. Patients were divided into groups according to the dose at week 8 (…
Assessment of minimum clinically important difference in symptoms and functionality of Japanese patients with major depressive disorder following inadequate response to antidepressants
The MCIDs for the MADRS, SDS, and EQ-5D-5L -derived utility scores were estimated. Physicians focus more on depressive symptoms and prioritize symptom severity over improvements in functionality and activities of daily life, in contrast to patients, who prioritize such improvements
Health Systems, Economic Evaluations, Quality of Life (3 obras) · Internal Medicine (3 obras) · Medicine (3 obras) · Post-hoc analysis (3 obras) · Psychiatry (3 obras) · Minimal clinically important difference (2 obras) · Physical therapy (2 obras) · Positive and Negative Syndrome Scale (2 obras) · Post hoc (2 obras) · Psychosis (2 obras)